Cardiol Therapeutics Inc Class A (CRDL) — Financial Flexibility Index
Cardiol Therapeutics Inc Class A (CRDL) has a Financial Flexibility Index of -0.91x as of December 2025. Free cash flow of CA$-5.22 Million (operating CF CA$-5.23 Million minus capex CA$3.09K) represents -1% of total liabilities (CA$5.74 Million). Check how tangible is Cardiol Therapeutics Inc Class A's equity to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cardiol Therapeutics Inc Class A Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Cardiol Therapeutics Inc Class A across 9 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Cardiol Therapeutics Inc Class A.
Annual Financial Flexibility Index for Cardiol Therapeutics Inc Class A (2017–2025)
Year-by-year free cash flow to debt coverage for Cardiol Therapeutics Inc Class A. Explore Cardiol Therapeutics Inc Class A cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CAD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.15x | CA$-23.83 Million | CA$-23.85 Million | CA$5.74 Million | ▼ -18.3% |
| 2024 | -3.51x | CA$-25.04 Million | CA$-25.06 Million | CA$7.14 Million | ▼ -17.8% |
| 2023 | -2.98x | CA$-25.18 Million | CA$-25.18 Million | CA$8.45 Million | ▼ -7.8% |
| 2022 | -2.76x | CA$-27.15 Million | CA$-27.22 Million | CA$9.83 Million | ▼ -36.6% |
| 2021 | -2.02x | CA$-23.54 Million | CA$-23.55 Million | CA$11.64 Million | ▲ +42.0% |
| 2020 | -3.49x | CA$-9.14 Million | CA$-9.19 Million | CA$2.62 Million | ▲ +73.6% |
| 2019 | -13.19x | CA$-10.96 Million | CA$-11.38 Million | CA$830.83K | ▼ -192.2% |
| 2018 | -4.51x | CA$-10.88 Million | CA$-10.89 Million | CA$2.41 Million | ▼ -31.1% |
| 2017 | -3.44x | CA$-1.26 Million | CA$-1.29 Million | CA$366.76K | — |